No abstract available
MeSH terms
-
Antiviral Agents / therapeutic use
-
Gene Frequency
-
Genetic Predisposition to Disease
-
HLA-A Antigens / genetics*
-
HLA-DR Antigens / genetics
-
HLA-DRB1 Chains
-
Hepatitis B, Chronic / drug therapy
-
Hepatitis B, Chronic / genetics*
-
Hepatitis B, Chronic / immunology
-
Humans
-
Phenotype
-
Polymorphism, Genetic
-
Risk Assessment
-
Risk Factors
-
Treatment Outcome
Substances
-
Antiviral Agents
-
HLA-A Antigens
-
HLA-A*33 antigen
-
HLA-DR Antigens
-
HLA-DRB1 Chains